The aXess vascular access conduit. [Image from the Xeltis website]Xeltis announced today that it began European ...
Private equity firm GTCR announced today that it signed an agreement for Corza Medical to sell its Biosurgery business unit.
Endogenex announced today that it completed enrollment in the ReCET clinical study of its endoscopic diabetes treatment.
Alcon (NYSE:ALC) and RxSight (Nasdaq:RXST) announced that they entered into a non-exclusive intraocular lens (IOL) ...